Heme Biosynthesis and the Porphyrias 2021: Consensus Diagnoses, Variant Disorders, New & Emerging Therapies

  • Jun 9, 2021
  • 3 Comments

Heme Biosynthesis and the Porphyrias 2021: Consensus Diagnoses, Variant Disorders, New & Emerging Therapies

  • Friday, May 28, 2021

REGISTRATION NOW OPEN!

 

The Heme Biosynthesis and the Porphyrias 2021: Consensus Diagnoses, Variant Disorders, New & Emerging Therapies, is to be held October 15-17, 2021, at the Hyatt Regency Schaumburg near the Chicago O’Hare Airport.

This 2.5-day educational symposium will feature international and national experts who will present on the latest findings on the biology, transport, and regulation of heme biosynthesis; as well as the clinical features, management, and current and emerging treatments for the acute hepatic and erythropoietic porphyrias.

Meeting Highlights:

  • Expert international faculty
  • Latest clinical and basic research advances
  • Talk tables during breakfast and lunch
  • A separate clinical session for patients
  • The symposium offers up to 25 CME credits

Click Here for More Information and to Register

 

Special Patient Day Meeting

Join us for a special Patient Day Meeting during the Heme Biosynthesis Symposium!

With informational sessions and networking opportunities, this in-person and virtual event is a must-attend for all patients globally. This is an opportunity to learn up-to-date information, get all your questions answered and to make new acquaintances and friendships.

Highlights of the day include:

  • Latest diagnostic & treatments options
  • ?Educational sessions on each of the eight porphyrias
  • The importance of research
  • Pain management including the use of cannibas
  • Psychological issues and quality of life discussions
  • "Ask the Porphyrias Experts" open discussion panel

Don't miss out on this unique opportunity to participate in-person or online - registration is now open!

Register for the Patient Day Event Now!

https://www.porphyriassymposium.com/patient-day/